Published by Josh White on 20th April 2022
(Sharecast News) - Medical imaging technology company Polarean Imaging updated the market on its investigational drug‑device combination product on Wednesday, which uses hyperpolarised '129Xenon' gas to enhance magnetic resonance imaging (MRI) in pulmonary medicine.
URL: http://www.digitallook.com/dl/news/story/32616752/...